Agios Pharmaceuticals: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $109.9 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.87.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.73 per share.
The biopharmaceutical company posted revenue of $26.2 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $24.6 million.
Agios Pharmaceuticals shares have increased slightly more than 4% since the beginning of the year. The stock has decreased 44% in the last 12 months.